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Abstract.  We have previously reported the production 
of monoclonal antibodies directed against phosphotyro- 
sine,  which is the modification induced by many on- 
cogene products and growth factor receptors.  One of 
these antiphosphotyrosine antibodies (py20) was used 
in affinity chromatography to isolate phosphotyrosine 
(PY)-containing proteins from Rous sarcoma virus- 
transformed chick embryo fibroblasts (RSV-CEFs). 
Mice were immunized with these PY-proteins for the 
production of monoclonal antibodies to individual sub- 
strates.  Fifteen antibodies were generated in this way 
to antigens with molecular masses of 215,  76, 60,  and 
22 kD.  Antibodies to individual substrates were used 
to analyze the subcellular location in normal and 
RSV-CEFs.  Antibodies to the 215-  and 76-kD antigen 
stained focal contacts when used in immunofluores- 
cence microscopy while anti-22-kD protein antibodies 
resulted in punctate staining concentrated in the mar- 
gins of cells and in parallel arrays. Both distributions 
were altered in transformed cells. When cells were ex- 
tracted with nonionic detergent under conditions that 
stabilize the cytoskeleton, 50%  of the 76-kD protein 
and >90%  of the 22-kD protein fractionated with the 
cytoskeleton. This study offers a  new approach to both 
the identification of membrane skeletal proteins in 
fibroblasts and changes that occur upon transformation 
by an activated tyrosine kinase. 
M 
ANY  oncogenes  are  known  to  encode  tyrosine- 
specific protein kinases and presumably exert their 
effect by phosphorylating proteins present in nor- 
mal cells (6,  32, 44).  The target substrates of tyrosine ki- 
nases have proven difficult to identify and characterize since 
they are generally minor proteins present in cultured cells. 
A variety of tyrosine kinase substrates are known. These in- 
clude the cytoskeletal proteins vinculin (34, 50) and talin (15, 
42) together with integrin (31) that are thought to participate 
in  a  cytoskeleton to  membrane  linkage  (for reviews,  See 
references 8, 33).  Proteins termed calpactins (also referred 
to as p35 and p36 or lipocortins) are also known to be phos- 
phorylated by both the transforming tyrosine protein kinases 
(10, 16, 45) and the epidermal growth factor receptor kinase 
(24, 49). Calpactins have been shown to associate with mem- 
brane lipids (22, 24) and the cytoskeletal proteins actin and 
spectrin (20,  24)  in a  Ca÷÷-dependent  manner.  They have 
been localized just under the membrane in a number of cell 
types (2, 13, 28, 35, 40). Other tyrosine kinase substrates in- 
clude calmodulin (18), microtubule associated proteins (1), 
glycolytic enzymes (12),  and a 50-kD protein (21). 
Thus far there is little evidence Suggesting  a  functional 
connection between the phosphorylation of the known sub- 
strates and any of the properties of transformed cells. Indeed, 
recent  studies  have  shown  that cells  expressing  the  non- 
myristylated mutants of the transforming protein of Rous sar- 
coma virus,  pp60  ~,  are  not transformed (30,  37).  In this 
system, nonmyristylated p60src is no longer targeted to the 
membrane (14, 37),  but it still phosphorylates the known 
substrates. Other studies have demonstrated a good correla- 
tion between transformation and the association of the kinase 
with  the  cytoskeleton (29).  Clearly,  the  identification of 
other tyrosine kinase substrates is needed to evaluate the cru- 
cial cytoskeletal targets. 
Early attempts to identify tyrosine kinase substrates relied 
on two dimensional gel analysis, followed by partial alkaline 
hydrolysis (i.e., reference 11). Other studies have tested anti- 
bodies  to  proteins  that are  known to  reside  in the  same 
cytoskeletal network (focal contacts) as pp60 itself (31, 42, 
46,  50).  Antiphosphotyrosine (anti-PY) t  antibodies  have 
gained widespread use in recent years for the detection of 
tyrosine kinase substrates in transformed and growth factor 
treated cells (9, 17, 30, 41, 48, 52).  The use of anti-PY anti- 
bodies in immunofiuorescence microscopy has shown that 
normal cells possess a low level of PY proteins that are con- 
centrated in focal contacts (39),  and cells in development 
have PY proteins in close apposition to their plasma mem- 
brane (38, 51). We now report the use of an anti-PY monoclo- 
nal  antibody to purify substrates  from Rous  sarcoma vi- 
rus-transformed chick embryo fibroblasts (RSV-CEFs).  The 
mixture of substrates was used to immunize mice for the 
1. Abbreviations  used in this paper:  PY, phosphotyrosine; RSV, Rous sar- 
coma  virus;  RSV-CEF,  Rous  sarcoma virus-transformed chick  embryo 
fibroblasts. 
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The Journal of Cell Biology,  Volume  108, June  1989 2401-2408  2401 Figure 1. Immunoaffinity purification of tyrosine kinase substrates from RSV-CEE  An extract (A and D) was applied to a column of py20 
sepharose. The column was washed extensively and eluted with 5 mM phosphotyrosine. The unretarded protein (lanes B and E) and protein 
eluted with phosphotyrosine (lanes C, F, and G) were run on SDS-PAGE (7.5 % gel), transferred to immobilon and stained with India ink 
(lanes A-C) followed by Western blot analysis with t25I-py20  (lanes D-G).  The position of phosphotyrosine-containing proteins reactive 
with anti-pp60  ~'c (36)  and anti-calpactin I  (55)  antibodies are indicated by arrows.  For lanes D-F,  exposure  to the x-ray  film was  6  h 
whereas a 30-min exposure is represented in lane G to compare directly the py20 reactivity with the protein (lane C) and the 32p-labeled 
proteins (lane H). RSV-CEF cells were metabolically labeled with 32PO4, extracted, and passed through a column of py20-sepharose. The 
32p-labeled protein was eluted with phosphotyrosine, subjected to SDS-PAGE,  and transferred to immobilon.  Lane H  shows the pattern 
of phosphoproteins on the autoradiogram.  Randomly selected 32p-labeled bands (a-f, right) were excised from the blot, hydrolyzed, and 
processed for two-dimensional phosphoamino acid analysis. The positions of phosphoserine (S), phosphothreonine (T), and phosphotyro- 
sine (Y) are shown for reference in a. 
production of monoclonal antibodies to individual proteins. 
Antibodies to novel proteins of molecular masses of 215, 76, 
and 22 kD were detected. Immunofluorescence microscopy 
and detergent extraction results suggest that these proteins 
are  present  in  discrete  regions  of the  plasma  membrane 
cytoskeleton. 
Materials and Methods 
Affinity Chromatography and Hybridoma Production 
Primary cultures  of chick embryo fibroblasts were infected with RSV and 
grown at 41°C in DME containing 2% tryptone phosphate broth and 4% 
calf serum.  Cells were lysed directly on the tissue culture plate with buffer 
A (10 mM imidazole, 0.5 M NaCl,  1% Triton X-too, 0.2 mM vanadate, 0.2 
mM PMSE 2 mM NAN3, pH 7.3) at 4°C for 30 min (6-7 ml buffer/150 mm 
plate). The solution was clarified by centrifugation (100,OO0 g, 1 h), and the 
soluble protein was incubated with 1.5 ml py20-sepharose/50  ml lysate of 
the specified monoclonal  antibodies coupled to CNBr-activated  sepharose 
4B (4 mg antibody/ml sepharose).  After 1 h at 4°C the sepharose was col- 
lected by centrifugation, loaded into a column, and washed extensively with 
buffer B (0.1 M NaCI,  10 mM imidazole,  0.1% Triton X-100). The phos- 
phoproteins  were then eluted with buffer B containing 5 mM phosphotyro- 
sine, and the column was monitored by SDS-PAGE and Western blots using 
[J25I]-labeled py20 as described (26). 
Protein from RSV-CEF cells that specifically bound to the anti-PY anti- 
body column (see Fig.  1) was used to immunize mice for the production of 
monoclonal  antibodies.  Antigen injections consisted  of 0.2-0.5 mg protein 
subcutaneously  and intramuscularly  at l-mo intervals followed by four con- 
secutive  daily intravenous  injections  of 1OO-200 #g protein.  2 d after the 
last injection, the spleen was harvested,  and cells were fused with the non- 
secreting myeloma,  PAl (27). Cells were grown in hypoxanthine aminopte- 
rin thymidine media and tested after 8 d by an ELISA assay using the antigen 
protein adsorbed  to  the  wells  of 96-well  immulon II  plates  (Dynatech 
Laboratories,  Inc.,  Alexandria,  VA). Hybridomas testing  positive  by the 
ELISA  asssay  were  tested  by Western blots again on protein specifically 
bound to the anti-PY column. Selected hybridomas that tested positive by 
Western blots were cloned by limiting dilution and screened as above. 
Other Methods 
For immnnofluorescence  microscopy, cells were grown on glass coverslips 
and fixed 6 h after plating.  For anti-76-kD antibodies,  cells were fixed in 
4%  formaldehyde  overnight at 4°C and permeabilized with 0.5%  Triton 
X-t00 for 5 min. Anti-22-kD and anti-215-kD antibodies were fixed and 
permeabilized by treatment with methanol/acetone (1:1, vol/vol) at -20°C 
for 5 min, and air dried. Coverslips were treated with the hybridoma culture 
supernatants  described in the legend to Fig. 2 for 30 min at 37°C, washed 
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column and eluted with phosphotyrosine.  The protein specifically 
eluted from the py20 column (see lane C of Fig. 1) was used to im- 
munize  mice.  Hybridomas derived  from the  fusion  of immune 
spleen cells with a nonsecreting myeloma cell line were screened 
by ELISA and Western blots on the immunizing antigen. Cells were 
cloned and retested. This figure shows the results with 15 different 
monoclonal antibodies (lanes a--o) tested in a Western blot on pro- 
tein bound to the anti-PY column. Protein was run on a single slot 
gel, transferred to immobilon, and strips were then treated with cul- 
ture supernatants of cloned hybridomas (lanes a-o). Antibodies to 
pp60  v-~, 60 kD (lane p), or calpactin I, 38 kD (lane q), were in- 
cluded as markers.  Reactivity was then assessed with  ~2SI-labeled 
second antibody followed by autoradiography. 
and further treated with FITC anti-mouse antibodies. Controls using cul- 
ture supernatant of the parental myeloma cells were performed in parallel 
and were always negative. 
ELISA assays were performed essentially as described by Glenney et al. 
(27),  and Western blots were as described by Glenney (23).  32P-labeling 
and phosphoamino acid analysis were performed as done by Cooper and 
Hunter (11), as described previously (22).  Detergent extractions were per- 
formed as by Zokas and Glenney (55)  using a  buffer containing 48 mM 
K2HPO4,  14 mM NaH2PO4, 45 mM KH2PO4, pH 7.2. Talin was purified 
by the method of Burridge and Connell (8). 
Sucrose gradient fractionation was performed as follows:  PY-proteins 
were isolated from RSV-CEF cells by extraction and affinity chromatogra- 
phy as described above. The PY-proteins were then concentrated with a cen- 
tricon filter (Millipore Continental Water Systems, Bedford, MA) to 20% 
of the original volume. The protein was layered over a 5-20% sucrose gra- 
dient in buffer B and centrifuged 14 h at 45,000 rpm using a rotor (model 
SW60;  Beckman Instruments, Inc.,  Palo Alto, CA).  Fractions were col- 
lected from the bottom of the gradient (the pellet  was resuspended sep- 
arately and considered fraction  1); adjusted with SDS sample buffer; run 
on SDS-PAGE; transferred to immobilon; and stained with anti-PY, anti-76 
or anti-22-kD, or anti-src (36) monoclonal antibodies. Reactivity was as- 
sessed  using  1251-labeled  anti-mouse  followed  by  autoradiography  and 
quantitated with a  densitometer. 
Results 
Primary cultures of RSV-CEFs were used as the starting ma- 
terial to isolate proteins phosphorylated on tyrosine residues. 
Anti-PY  coupled to  Sepharose removed >50%  of the  PY 
proteins that were then eluted from the columns with the in- 
clusion of PY (Fig.  1). We compared the profile of proteins 
specifically eluted from the anti-PY column and stained with 
India ink to the proteins reactive with the anti-PY by Western 
blots and those metabolically labeled with 32p. A  good cor- 
respondence was observed between these profiles, suggest- 
ing that the majority of proteins bound and eluted from the 
anti-PY  column are phosphoproteins.  Phosphoamino  acid 
analysis of randomly selected 32P-labeled  proteins demon- 
strated that the proteins contained PY although at different 
ratios to phosphoserine  (Fig.  1).  When  normal and  RSV- 
CEF proteins were metabolically labeled with [3~S]methio- 
nine and subjected to affinity chromatography, 0.6%  of the 
total TCA insoluble radioactivity from RSV-CEF cells bound 
to the anti-PY antibody column whereas <0.1% of the radio- 
activity from normal fibroblasts bound to the column. None 
of the 32p-labeled proteins that bound to the anti-PY column 
(Fig.  1) were observed when the same experiment was per- 
formed with normal chick fibroblasts (not shown)  indicat- 
ing  that  the  tyrosine  phosphorylations  are  transformation 
specific. 
The mixture of proteins from RSV-CEF cells purified by 
immunoaffinity chromatography on the anti-PY column were 
used to immunize two BALB/c mice. The spleen ceils from 
these mice were fused with a nonsecreting myeloma cell line, 
and the resulting hybrids were plated into 96-well tissue cul- 
ture plates. Hybridoma culture supernatants were tested by 
an ELISA assay using test plates to which anti-PY-bound 
proteins  were adsorbed.  Antibodies  that tested positive in 
this assay were further screened by immunoblotting against 
the affinity isolated tyrosine phosphoproteins. From two fu- 
sions,  we observed several hundred  hybridomas that  gave 
rise to a positive reaction by the ELISA, and 50 of these anti- 
bodies were strongly reactive by Western blots.  15 different 
antibody  secreting cells were then selected and cloned by 
limiting dilution  for further study (Fig.  2). 
The selected monoclonal antibodies reacted with proteins 
displayed on a  Western blot (Fig.  2).  Three antibodies re- 
acted with a discrete high molecular mass (~215-kD) com- 
ponent and more diffuse lower molecular mass polypeptides 
(lanes a-c), reminiscent of proteolysis. These antibodies did 
not react with the 215-kD cytoskeletal protein talin isolated 
from chicken gizzard (8) when run in parallel lanes on the 
same blot (data not shown). Two antibodies react with a mul- 
titude of components between 60-200  kD (Fig.  2,  lanes d 
and e). These may be reacting with shared epitopes such as 
the carbohydrate moiety on glycoproteins. Regardless of the 
reason for this broad specificity, these antibodies may be less 
useful than those that show a more limited reactivity. Four 
different antibodies react with a relatively diffuse component 
having an apparent molecular mass of 76  kD  (lanes f-i). 
Three antibodies react with a 60-kD protein that co-migrates 
with the tyrosine kinase pp60  ..... (compare lanes j-l to lane 
p). Finally, three antibodies (lanes m-o) react predominantly 
with a 22-kD component although they also react to a lesser 
extent  with  other  higher  molecular  mass  species.  These 
higher species are not seen in total cell lysates (see Fig. 6). 
Glenney et al. New Cytoskeletal Tyrosine  Kinase Substrates  2403 Figure 3.  Immunofluorescence localization of antigens in normal and RSV-CEFs. Monoclonal antibodies against the 215-kD antigen (E 
and F), the 22-kD antigen (C and D), and the 76-kD antigen (A and B) (see Fig. 2, lanes a, m, and f, respectively) were used in indirect 
immunofluorescence microscopy on normal  (A, C, and E) and RSV-transformed (B, D, and F) cells. 
Antibodies that react with 215-kD (Fig. 2, lane a), 76-kD 
(Fig.  2,  lane h),  and 22-kD (Fig.  2,  lane m) proteins were 
used to localize these components by immunofluorescence 
microscopy on normal and RSV-CEFs (Fig.  3).  Antibodies 
to  the  60-kD  proteins  have thus  far been  negative  in  im- 
munofluorescence  microscopy.  The  staining  with anti-22- 
kD  antibodies  resulted  in  punctate  fluorescence,  in  many 
cases concentrated in parallel arrays and at the cell margins. 
The Journal of Cell Biology, Volume  108. 1989  2404 Figure 4.  Double-label  immunoftuorescence  microscopy with anti-76-kD antibodies.  Anti-76-k monoclonal antibody  was detected with 
a fluorescein anti-mouse second antibody (A, C) while the actin distribution was visualized with rhodamine-pholloidin  (B). The distribu- 
tion of vinculin was detected with rabbit anti-vinculin and rhodamine anti-rabbit second antibody (D). A and B represent  images of the 
same cell as do C and D. 
This  staining  gave the  distinct  impression  of a  submem- 
branous location although unlike the fodrin or calpactin dis- 
tribution  previously observed in  fibroblasts (55).  In  RSV- 
transformed cells, punctate fluorescence was again observed 
but without the concentrations at the margins or in parallel 
arrays. 
Antibodies to both the 215-kD protein (Fig.  3, E  and F) 
and to the 76-kD component (Fig. 3 A and B) reacted with 
structures predominantly on the ventral surface of the cell. 
Control monoclonal antibodies (see above) did not result in 
this pattern. The anti-76-kD staining was much more diffuse 
in  transformed cells (Fig.  3).  Since  this  antibody  staining 
pattern  was  reminiscent  of the  staining  of focal  contacts, 
those specialized cell adhesions  where actin filament bun- 
dles terminate close to the plasma membrane (3, 7,  19), we 
counterstained  cells with rhodamine-conjugated  phalloidin 
to detect the actin distribution or with anti-vinculin antibod- 
ies to observe the focal contact distribution. As shown in Fig. 
4,  anti-76-kD  protein  stained  the  ends of actin-containing 
stress fibers, giving rise to the so-called focal contact stain- 
ing.  This  was  confirmed  by  double  label  immunofluores- 
cence that showed costaining of focal contacts with anti-76 
kD and anti-vinculin. 
The  anti-76-kD  antibodies  were  then  used  to  immuno- 
precipitate  a  similar size  phosphoprotein  from 32p-labeled 
RSV-CEF cells (Fig.  5).  Higher molecular mass phospho- 
proteins were specifically coprecipitated as these bands were 
not observed when control mouse IgG was used (not shown). 
They may represent complexes with the 76-kD protein since 
they are not recognized by the antibody on a Western blot. 
Phosphoamino acid analysis demonstrated the presence of 
PY in the 76-kD protein (Fig. 5). Furthermore, it was found 
by Western blots that 20-30%  of the total 76-kD protein in 
RSV-CEF cells would bind to the anti-PY column, pointing 
to a  significant stoichiometry of tyrosine phosphorylation, 
while no 76-kD protein from normal CEF cells was bound 
to the column (not shown).  Similarly,  the  immunoprecipi- 
tated 22-kD substrate protein has now been found to contain 
phosphotyrosine (not shown). 
Since immunofluorescence microscopy suggested that these 
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CEF cells were labeled overnight with 32po4, extracted, and the 
phosphotyrosine-containing proteins (A) were bound to the py20 
antibody and eluted with phosphotyrosine.  Anti-76-kD antibody 
was then used to immunoprecipitate the 76-kD antigen (arrow)  that 
was subjected to phosphoamino acid analysis (C) as described in 
the legend to Fig. 2. When control mouse IgG was substituted, no 
precipitation of this band was observed. 
antigens are in a cytoskeletal organization, we extracted cells 
with a detergent solution under conditions that stabilize the 
cytoskeleton. Surprisingly, two of the four anti-76-kD anti- 
bodies also recognized a 44-kD antigen in total cell lysates, 
but only the 76-kD protein was retained by the anti-PY col- 
umn (Fig. 6). Fractionation of cellular protein into detergent 
soluble and cytoskeletal components revealed that '~50% of 
both the 76- and 44-kD proteins are soluble. By contrast, 
>90% of the 22-kD protein was found in the detergent resis- 
tant cytoskeleton under these conditions. There was no dif- 
ference in the extractability of these proteins between normal 
and RSV-CEFs (not shown). 
Discussion 
The oncogenic tyrosine-specific protein kinases src (46) and 
abi  (47)  are found associated with  focal contacts and  the 
transforming ability correlates with its presence in the cyto- 
skeleton  (29).  Many  of the  substrates  of pp60 src  are  also 
known to be cytoskeletal proteins. These include calpactin, 
vinculin, talin, and integrin (see introduction for references). 
In addition, antibodies to phosphotyrosine have been shown 
to stain focal contacts in normal cells (9, 39). Indeed, altera- 
tions in the cytoskeleton are some of the earliest changes ob- 
served when cells become transformed (3, 43, 53,  54). Un- 
fortunately, none of the previously described substrates are 
correlated with parameters associated with transformed cells 
(30, 37). Thus, although the cytoskeleton is tightly associated 
with the transforming ability of pp6@ re,  the  relevant sub- 
strates have yet to be described. 
The present study provides an alternative approach to the 
identification and study of cytoskeletal tyrosine kinase sub- 
strates. Rather than testing previously identified cytoskeletal 
proteins, we have generated monoclonal antibodies to a mix- 
ture of PY proteins phosphorylated in vivo and used the anti- 
bodies to test the association of these normal cellular pro- 
teins with other cellular structures. The anti-PY monoclonal 
antibody we have been using to isolate substrates has been 
found to be some  100-fold higher in affinity than the com- 
mercially  available  antibody  1G2  (Jamison  and  Glenney, 
manuscript in preparation).  Previous studies demonstrated 
that this antibody would block the internalization of the acti- 
vated epidermal growth factor receptor when microinjected 
into live cells (26). In the present study, we have used the 
anti-PY column to isolate the PY-proteins from RSV-CEFs 
followed by the generation of monoclonal antibodies to in- 
dividual  substrates.  Given that  the  relevant substrates  are 
also unknown for a variety of growth factor receptor tyrosine 
kinases, the approach presented here should find general ap- 
plication.  Currently,  we  are  using  the  same  approach  to 
generate antibodies to substrates  of the epidermal growth 
factor receptor. Preliminary results have shown that the 76- 
kD  protein described here is  phosphorylated in  mouse  L 
cells that have been transfected with the epidermal growth 
factor receptor and  treated  with  epidermal  growth  factor 
(data not shown). 
In the present study, we have identified three new tyrosine- 
kinase substrate proteins of the membrane skeleton. A 215- 
kD protein (Fig. 2) is similar in molecular mass and subcel- 
lular distribution to another substrate, talin (8,  15, 42); how- 
ever, antibodies to the 215-kD substrate did not react with 
gizzard talin (see Results).  Antibodies to a  76-kD protein 
stain focal contacts in permeabilized cells (Figs. 3 and 4) and 
immunoprecipitate a PY protein from metabolically labeled 
transformed cells (Fig. 5). It is possible that the 76-kD pro- 
tein is similar to an 82-kD protein present in focal contacts 
(4) or to the 82-kD Ca  ++ dependent protease that has also 
been found in focal contacts (5). Neither of  these proteins has 
been  reported to  be phosphorylated on tyrosine in  trans- 
formed cells.  Two of the  four anti-76-kD  antibodies  also 
recognize a 44-kD antigen among total cellular proteins. The 
relationship between the 76- and 44-kD proteins is unknown, 
but it seems unlikely that the 44-kD protein is derived from 
the 76-kD protein by proteolysis since the 44-kD protein is 
found in cells lysed in boiling sample buffer (Fig. 6) presum- 
ably denaturing endogenous proteases.  Future studies will 
address the question of whether both the 76- and 44-kD pro- 
teins  are  present  in  focal contacts.  The 76-kD  protein  is 
different in size than other known tyrosine kinase substrates. 
Anti-76-kD antibodies react with a broad band,  suggesting 
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and 22-kD  antigens  in the cyto- 
skeleton of RSV-CEF cells. Total 
CEF (a) or RSV-CEF (b-d) cells 
were lysed in SDS sample buffer 
(a and b) or a nonionic detergent 
solution  and  separated  into  an 
equal volume of soluble (c) and cy- 
toskeletal (d) fractions and com- 
pared to the position of the anti- 
gen bound to the py20 column (e). 
Proteins were analyzed by West- 
ern blots  using anti-76-kD  (lefl, 
7.5 % gel) or anti-22-kD (right, 
11.5% gel) antibodies.  Lines  in- 
dicate the position of the protein 
standards  spectrin  (S),  vinculin 
(I/), BSA (B),  actin (A), calpac- 
tin (C), soybean trypsin inhibitor 
(ST),  or cytochrome  c  (Cy)  run 
on the same gel. 
an extensive posttranslationai modification such as glycosy- 
lation.  The fibronectin receptor (integrin)  is an example of 
an integral membrane protein that is thought to interact with 
cytoskeletal proteins inside the cell and to be phosphorylated 
on tyrosine residues (for review, see reference 33). Integrin 
polypeptides, however, have a significantly higher apparent 
molecular mass (31), and no integrin polypeptides of 70-80 
kD have been described. Whereas integrin, vinculin, and ta- 
lin are phosphorylated to a very low level (1%), preliminary 
studies  have  shown  that  20-30%  of the  76-kD  protein  is 
phosphorylated in RSV-transformed cells (see Results).  We 
are currently analyzing the sites and extent of tyrosine phos- 
phorylation of all of the proteins described here. 
Antibodies were also generated to a 22-kD protein that was 
retained on the anti-PY column.  The immunofluorescence 
staining pattern with anti-22-kD antibody is unlike any dis- 
tribution  previously  seen.  In  normal  fibroblasts,  brightly 
fluorescent submembranous "patches" were found in parallel 
arrays and concentrated at the cell margins; while in trans- 
formed cells,  no discernable  organization of this punctate 
fluorescence was seen. All three of the anti-22-kD antibod- 
ies gave the same staining pattern. The cytoskeletal disposi- 
tion of the 22-kD protein was confirmed by detergent extrac- 
tion experiments (Fig.  6).  Although the molecular mass of 
the 22-kD protein is similar to calmodulin, another of the 
tyrosine  kinase  substrates  (18),  calmodulin  is  not  strictly 
cytoskeletal and is present at high levels in the brain, whereas 
the  22-kD  protein  is  absent  from brain  (Glenney,  unpub- 
lished observation). Furthermore, the 22-kD protein released 
with high  salt sedimented in  a  position characteristic  of a 
much higher native molecular mass (not shown). It is possi- 
ble that the 22-kD substrate may be tightly associated with 
other  subunits  that  may themselves be phosphorylated on 
tyrosine in transformed cells. Future studies will have to ad- 
dress the molecular associations that occur in these 22-kD- 
rich regions visualized by immunofluorescence microscopy. 
The transforming ability of src requires an active protein 
tyrosine kinase activity in addition to the association with the 
membrane skeleton. Mutants of p60 have been generated, for 
instance, that lack the site of myristylation and are no longer 
associated with the membrane and cytoskeleton (14,  29,  37) 
and are not transforming. This has provided a crucial test of 
the relevance of the phosphorylation of known substrates to 
changes that occur in transformation. We are currently evalu- 
ating the phosphorylation of the substrates described here in 
cells expressing the nonmyristylated mutants of src. Prelimi- 
nary results indicate that the phosphorylation of the 22-kD 
protein is correlated with transformation in this system. The 
approach described  here  should  provide us with the  tools 
needed  to study the proteins that  mediate the cytoskeletal 
changes in transformed cells. 
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